RapidArc Dynamic improves pelvic organ sparing versus VMAT in endometrial boost planning

In 30 endometrial cancer cases, RapidArc Dynamic improved pelvic OAR sparing and dose fall-off compared with VMAT, but required more monitor units.

KEY POINTS

  • This retrospective single-center planning study included 30 patients with high-intermediate-risk endometrial cancer previously treated with simultaneous integrated boost radiotherapy. Three plans were generated for each patient, comparing RapidArc Dynamic (RAD), nine-field IMRT, and two-arc VMAT, for a total of 90 plans. All plans prescribed 50.4 Gy in 28 fractions to the PTV and 61.6 Gy in 28 fractions to the nodal CTV, with identical initial planning objectives.
  • RapidArc Dynamic combined two full arcs with static angle-modulated ports (STAMPs) at gantry angles 0° and 181°, allowing additional modulation during gantry pauses. RAD used 6-MV flattening-filter-free beams at 1400 MU/min, whereas IMRT and VMAT used conventional 6-MV beams at 600 MU/min. All plans were generated in Eclipse and normalized to ensure that 95% of the PTV received 50.4 Gy.
  • Target coverage remained favorable with all three techniques, although VMAT provided lower nodal boost coverage. Mean CTVn D95 was 62.41 ± 2.35 Gy with RAD, compared with 63.03 ± 1.44 Gy for IMRT and 61.62 ± 1.94 Gy for VMAT. Differences were statistically significant for RAD versus VMAT (p=0.038) and IMRT versus VMAT (p=0.004), while IMRT showed the strongest control of high-dose hotspots.
  • RAD achieved improved dose conformity and intermediate-dose fall-off compared with conventional VMAT. Mean PTV conformity index was 0.833 with RAD, compared with 0.835 for IMRT and 0.813 for VMAT (RAD vs VMAT, p=0.002). The 50% dose-spillage ratio was lowest with RAD (R50% 3.45) versus 3.86 with IMRT (p=0.001) and 3.67 with VMAT (p=0.028), indicating a sharper reduction in dose outside the target.
  • RAD plans showed fewer OAR constraint violations, especially for the small bowel and bladder. The small-intestine D2cc ≤52 Gy constraint was exceeded in 13 RAD plans versus 23 IMRT and 29 VMAT plans, while the bladder D2cc ≤53.5 Gy constraint was exceeded in 3, 9, and 13 plans, respectively. RAD also reduced several rectal and bone marrow dose metrics, although all 90 plans exceeded the bone marrow V10 <90% objective, demonstrating that its dosimetric improvements did not eliminate all planning limitations.
  • Delivery-related parameters showed important trade-offs. Mean monitor units were 1314.7 for RAD, compared with 3334.0 for IMRT and only 527.8 for VMAT. Mean modulation complexity scores were 0.16, 0.03, and 0.26, respectively, indicating that RAD was less complex than fixed-field IMRT but more complex than conventional VMAT. Consequently, RAD cannot be described as the simplest or most monitor-unit-efficient technique.
  • The analysis was restricted to retrospectively optimized treatment plans, without patient-specific delivery QA results, directly measured beam-on times, or toxicity outcomes. Differences in beam type and maximum dose rate further complicate expected treatment-time comparisons, while the relatively large 8-mm PTV margin and selected STAMP geometry may not generalize to other institutions or contemporary adaptive protocols.

CLINICAL TAKEAWAY

RapidArc Dynamic may improve the dosimetric quality of endometrial cancer SIB plans by reducing exposure to the bowel, bladder, rectum, and marrow while maintaining favorable nodal boost coverage. However, these advantages were demonstrated only in a single-center planning comparison, and the increased monitor units relative to VMAT, different delivery configurations, and absence of measured clinical or treatment-time outcomes require further validation.

SOURCE

Radiation Oncology

Browse more research Suggest a correction